01 2ADO-TRASTUZUMAB EMTANSINE
02 3ALTEPLASE
03 2ATEZOLIZUMAB
04 1ATEZOLIZUMAB AND HYALURONIDASE-TQJS
05 6BALOXAVIR MARBOXIL
06 2BEVACIZUMAB
07 1COBIMETINIB FUMARATE
08 1CROVALIMAB-AKKZ
09 1DORNASE ALFA
10 4EMICIZUMAB
11 5ENTRECTINIB
12 1FARICIMAB-SVOA
13 2GLOFITAMAB-GXBM
14 2INAVOLISIB
15 2MOSUNETUZUMAB-AXGB
16 1OBINUTUZUMAB
17 1OCRELIZUMAB
18 1OCRELIZUMAB AND HYALURONIDASE-OCSQ
19 4OMALIZUMAB
20 1PERTUZUMAB
21 2PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF
22 2POLATUZUMAB VEDOTIN-PIIQ
23 3RANIBIZUMAB
24 2RISDIPLAM
25 2RITUXIMAB
26 2RITUXIMAB; HYALURONIDASE (HUMAN RECOMBINANT)
27 1SATRALIZUMAB
28 8SOMATROPIN
29 1SOMATROPIN [rDNA origin]
30 1TENECTEPLASE
31 4TOCILIZUMAB
32 1TRASTUZUMAB
33 1TRASTUZUMAB AND HYALURONIDASE-OYSK
34 1VISMODEGIB
01 5CAPSULE;ORAL
02 1FOR SOLUTION;ORAL
03 3FOR SUSPENSION;ORAL
04 5INJECTABLE; INJECTION
05 1INJECTABLE; INTRAVITREAL
06 22INJECTABLE;INJECTION
07 1INJECTABLE;INTRAVENOUS
08 1INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
09 3INJECTABLE;SUBCUTANEOUS
10 2Injectable; Injection
11 1PELLETS;ORAL
12 2POWDER;INTRAVENOUS
13 1SOLUTION;INJECTION
14 2SOLUTION;INTRAVENOUS
15 2SOLUTION;SUBCUTANEOUS
16 3SYRINGE
17 7TABLET;ORAL
18 4VIAL
19 3VIAL; INTRAVENOUS
20 5VIAL; SINGLE-USE
01 10.75MG/ML
02 11,200MG;600MG;30,000UNITS
03 11000MG/40ML
04 4100MG
05 1100MG/10ML (10MG/ML)
06 1100MG/ML
07 1100MG/VIAL
08 1105MG/0.7ML
09 110MG/10ML(1MG/ML)
10 310MG/2ML (5MG/ML)
11 110MG/ML
12 110MG/VIAL
13 21200MG/20ML
14 2120MG/ML
15 1125MG;2000UNITS PER ML
16 11400MG and 23400UNITS/11.7ML
17 1140MG/VIAL
18 2150MG
19 1150MG/ML
20 1150MG/VIAL
21 11600MG and 26800UNITS/13.4ML
22 1160MG
23 1162MG/0.9ML
24 21MG/ML
25 12.5MG/2.5ML(1MG/ML)
26 2200MG
27 1200MG/10ML
28 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
29 220MG/2ML (10MG/ML)
30 121MG/ML
31 12MG/ML
32 12MG/VIAL
33 1300MG/2ML
34 130MG/1ML
35 130MG/30ML
36 130MG/ML
37 130MG/PACKET
38 130MG/VIAL
39 1340MG/2ML(170MG/ML)
40 13MG
41 1400MG
42 1400MG/20ML
43 140MG
44 140MG/PACKET
45 140MG;1000UNITS PER ML
46 1420MG/14ML
47 1500MG/50ML (10MG/ML)
48 150MG/PACKET
49 250MG/VIAL
50 15MG
51 15MG/2ML (2.5MG/ML)
52 15MG/VIAL
53 1600MG;10000UNITS
54 1600MG;600MG;20,000UNITS
55 160MG/0.4ML
56 16MG/ML
57 175MG/0.5ML
58 180MG
59 180MG/4ML
60 19MG
61 1EQ 20MG BASE
62 1N/A
01 1DISCN
02 14RX
03 59Blank
RLD :
TE Code :
Dosage Form : VIAL; SINGLE-USE
Proprietary Name : KADCYLA
Dosage Strength : 100MG
Approval Date :
Application Number : 125427
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : VIAL; SINGLE-USE
Proprietary Name : KADCYLA
Dosage Strength : 160MG
Approval Date :
Application Number : 125427
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : VIAL; SINGLE-USE
Proprietary Name : ACTIVASE
Dosage Strength : 100MG/VIAL
Approval Date :
Application Number : 103172
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : VIAL; SINGLE-USE
Proprietary Name : ACTIVASE
Dosage Strength : 50MG/VIAL
Approval Date :
Application Number : 103172
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : VIAL
Proprietary Name : CATHFLO ACTIVASE
Dosage Strength : 2MG/VIAL
Approval Date :
Application Number : 103172
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : TECENTRIQ
Dosage Strength : 1200MG/20ML
Approval Date :
Application Number : 761034
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : TECENTRIQ
Dosage Strength : 1200MG/20ML
Approval Date :
Application Number : 761041
RX/OTC/DISCN :
RLD :
TE Code :
RLD :
TE Code :
ATEZOLIZUMAB AND HYALURONIDASE-TQJS
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : TECENTRIQ HYBREZA
Dosage Strength : 125MG;2000UNITS PER ML
Approval Date :
Application Number : 761347
RX/OTC/DISCN :
RLD :
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : XOFLUZA
Dosage Strength : 20MG **Federal Register ...
Approval Date : 2018-10-24
Application Number : 210854
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : TABLET; ORAL
Proprietary Name : XOFLUZA
Dosage Strength : 40MG
Approval Date : 2018-10-24
Application Number : 210854
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Genentech is a supplier offers 6 products (APIs, Excipients or Intermediates).
Find DORNASE ALFA INHALATION SOLUTION (GENENTECH) bulk offered by Genentech
Find CED88004S bulk offered by Genentech
Find THROMBOPOIETIN (HUMAN, RECOMBINANT, CHO CELLS, GENENTECH) bulk offered by Genentech
Find CED88004A bulk offered by Genentech
Find TUMOR NECROSIS FACTOR RECEPTOR IMMUNOGLOBULIN G bulk offered by Genentech
Find MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN SOUTH SAN FRANCISCO. bulk offered by Genentech
